Internal 1,15-lactones of fluprostenol and related prostaglandin F2alpha analogs and their use in the treatment of glaucoma and intraocular hypertension

Details for Australian Patent Application No. 2001233286 (hide)

Owner Cayman Chemical Company, Inc.

Inventors Maxey, Kirk M; Stanton, Michelle L.

Agent Pizzeys

Pub. Number AU-B-2001233286

PCT Pub. Number WO01/57015

Priority 60/179,508 01.02.00 US

Filing date 1 February 2001

Wipo publication date 14 August 2001

Acceptance publication date 6 April 2006

International Classifications

C07D 313/00 (2006.01) Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom

A61K 31/365 (2006.01) - Lactones

A61P 27/06 (2006.01) Drugs for disorders of the senses

Event Publications

6 April 2006 Application Accepted

  Published as AU-B-2001233286

3 August 2006 Standard Patent Sealed

21 July 2011 Alteration of Name

  The name of the patentee has been altered to Cayman Chemical Company, Incorporated 2002

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001233287

2001233285